You are here

IDF Consulting Immunologist Program

Nurse Advisory Committee Give your patients the benefit of a second medical opinion on primary immunodeficiency diseases (PI) from a national network of renowned immunologists.

  • Free physician-to-physician consults or second opinions on issues of diagnosis, treatment and disease management
  • Access to a faculty of recognized leaders in clinical immunology

Questions range from interpreting laboratory testing to choosing appropriate medical therapies to working effectively with insurance company denials and questions. The consult might be about a newly diagnosed patient or someone who does not seem to fit any specific PI diagnosis. All questions regarding patients are welcomed, and requests are forwarded on to a skilled immunologist working with this program. Created to serve the needs of physicians who have questions about their patients with PI, this physician-to-physician service has provided hundreds of free consults to physicians.

What Physicians Are Saying about the IDF Consulting Immunologist Program

  • “The IDF Consulting Immunologist Program is a wonderful resource for clinicians for assistance with immunology questions. I will definitely be using the program again in the future.”
  • “This is truly a wonderful service, and the gift of time and advice from the participating faculty is greatly appreciated.”

Click here to submit your request to the IDF Consulting Immunologist Program


The IDF Consulting Immunologist Program is for Physicians only. Please consult your physician if you have any questions about your health or treatment. You may want to share information about the IDF Consulting Immunologist Program with your physician.

Click here to download an Information Card

Do not use this for medical emergencies. If you are experiencing a medical emergency, contact your healthcare professional immediately or call 911.

This program is supported by:
CSL Behring, Grifols, Takeda
Horizon Therapeutics, Octapharma
Bio Products Laboratory, Leadiant Biosciences, Orchard Therapeutics